Folgen
Constantinos Zamboglou
Constantinos Zamboglou
German Oncology Center
Bestätigte E-Mail-Adresse bei goc.com.cy
Titel
Zitiert von
Zitiert von
Jahr
Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis
P Papatheodorou, C Zamboglou, S Genisyuerek, G Guttenberg, ...
PloS one 5 (5), e10673, 2010
2052010
Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison …
C Zamboglou, V Drendel, CA Jilg, HC Rischke, TI Beck, ...
Theranostics 7 (1), 228, 2017
1682017
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate-and high-risk prostate cancer-a …
C Zamboglou, M Carles, T Fechter, S Kiefer, K Reichel, TF Fassbender, ...
Theranostics 9 (9), 2595, 2019
1312019
68Ga-HBED-CC-PSMA PET/CT versus histopathology in primary localized prostate cancer: a voxel-wise comparison
C Zamboglou, F Schiller, T Fechter, G Wieser, CA Jilg, A Chirindel, ...
Theranostics 6 (10), 1619, 2016
1162016
[68Ga-] PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard …
AS Bettermann, C Zamboglou, S Kiefer, CA Jilg, S Spohn, ...
Radiotherapy and Oncology 141, 214-219, 2019
1022019
MRI versus 68Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer
C Zamboglou, G Wieser, S Hennies, I Rempel, S Kirste, M Soschynski, ...
European journal of nuclear medicine and molecular imaging 43, 889-897, 2016
942016
Outcome after PSMA PET/CT–based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a 2-institution retrospective analysis
NS Schmidt-Hegemann, C Stief, TH Kim, C Eze, S Kirste, I Strouthos, M Li, ...
Journal of Nuclear Medicine 60 (2), 227-233, 2019
792019
Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference
C Zamboglou, B Thomann, K Koubar, P Bronsert, T Krauss, HC Rischke, ...
Radiation oncology 13, 1-9, 2018
652018
Impact of 68Ga-PSMA PET/CT on the radiotherapeutic approach to prostate cancer in comparison to CT: a retrospective analysis
NS Schmidt-Hegemann, C Eze, M Li, P Rogowski, C Schaefer, C Stief, ...
Journal of Nuclear Medicine 60 (7), 963-970, 2019
622019
Radiomics in prostate cancer imaging for a personalized treatment approach-current aspects of methodology and a systematic review on validated studies
SKB Spohn, AS Bettermann, F Bamberg, M Benndorf, M Mix, NH Nicolay, ...
Theranostics 11 (16), 8027, 2021
612021
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference
C Zamboglou, TF Fassbender, L Steffan, F Schiller, T Fechter, M Carles, ...
Radiotherapy and Oncology 141, 208-213, 2019
572019
Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 …
C Zamboglou, AS Bettermann, C Gratzke, M Mix, J Ruf, S Kiefer, CA Jilg, ...
European journal of nuclear medicine and molecular imaging 48, 1987-1997, 2021
522021
Intraprostatic tumor segmentation on PSMA PET images in patients with primary prostate cancer with a convolutional neural network
D Kostyszyn, T Fechter, N Bartl, AL Grosu, C Gratzke, A Sigle, M Mix, ...
Journal of Nuclear Medicine 62 (6), 823-828, 2021
482021
Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective …
S Spohn, C Jaegle, TF Fassbender, T Sprave, E Gkika, NH Nicolay, ...
European Journal of Nuclear Medicine and Molecular Imaging 47, 2796-2803, 2020
482020
Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68Ga-HBED-CC PSMA-PET/CT: a planning study based on histopathology reference
C Zamboglou, I Sachpazidis, K Koubar, V Drendel, R Wiehle, S Kirste, ...
Radiotherapy and Oncology 123 (3), 472-477, 2017
472017
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
S Zschaeck, F Lohaus, M Beck, G Habl, S Kroeze, C Zamboglou, ...
Radiation oncology 13, 1-9, 2018
452018
A clinical evaluation of the performance of five commercial artificial intelligence contouring systems for radiotherapy
PJ Doolan, S Charalambous, Y Roussakis, A Leczynski, M Peratikou, ...
Frontiers in oncology 13, 1213068, 2023
422023
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary …
SKB Spohn, M Kramer, S Kiefer, P Bronsert, A Sigle, ...
Frontiers in oncology 10, 600690, 2020
372020
Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology
DD Gunashekar, L Bielak, L Hägele, B Oerther, M Benndorf, AL Grosu, ...
Radiation Oncology 17 (1), 65, 2022
352022
Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
TF Fassbender, F Schiller, C Zamboglou, V Drendel, S Kiefer, CA Jilg, ...
EJNMMI research 10, 1-11, 2020
322020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20